151 related articles for article (PubMed ID: 36184421)
1. The changing role for extended resections in an era of advanced radiotherapy techniques and novel therapies in gynaecological malignancy.
McBain RD; McGauran MFG; Tran KH; Au-Yeung G; Khaw PYL; McNally OM
Eur J Surg Oncol; 2022 Nov; 48(11):2308-2314. PubMed ID: 36184421
[TBL] [Abstract][Full Text] [Related]
2. [Pelvic exenterations for gynaecological cancer--a 10 year institutional review].
Pinelo S; Petiz A; Domingues C; Lopes C; Alves A; Fael R
Acta Med Port; 2006; 19(2):99-104. PubMed ID: 17187709
[TBL] [Abstract][Full Text] [Related]
3. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).
Arians N; Foerster R; Rom J; Uhl M; Roeder F; Debus J; Lindel K
Radiat Oncol; 2016 Mar; 11():44. PubMed ID: 26988089
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration.
Barber HR
Cancer Invest; 1987; 5(4):331-8. PubMed ID: 3311312
[TBL] [Abstract][Full Text] [Related]
7. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
8. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
9. Pelvic Exenteration Surgery: The Evolution of Radical Surgical Techniques for Advanced and Recurrent Pelvic Malignancy.
Brown KGM; Solomon MJ; Koh CE
Dis Colon Rectum; 2017 Jul; 60(7):745-754. PubMed ID: 28594725
[TBL] [Abstract][Full Text] [Related]
10. Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.
Moreno-Palacios E; Diestro MD; De Santiago J; Hernández A; Zapardiel I
Int J Gynecol Cancer; 2015 Jul; 25(6):1109-14. PubMed ID: 25853383
[TBL] [Abstract][Full Text] [Related]
11. Urinary conduit in pelvic cancer patients. A report of 16 years' experience.
Swan RW; Rutledge FN
Am J Obstet Gynecol; 1974 May; 119(1):6-13. PubMed ID: 4820911
[No Abstract] [Full Text] [Related]
12. Pelvic exenteration in gynaecologic oncology: analysis of 44 cases.
Bompiani A; Benedetti Panici P; Greggi S; Margariti PA; Di Roberto P
Eur J Gynaecol Oncol; 1985; 6(3):165-9. PubMed ID: 4054145
[TBL] [Abstract][Full Text] [Related]
13. The role of surgery in the management of recurrent gynecologic cancer.
Hogan WM; Boente MP
Semin Oncol; 1993 Oct; 20(5):462-72. PubMed ID: 7692604
[No Abstract] [Full Text] [Related]
14. Psychosocial adjustment to pelvic exenteration.
Dempsey GM; Buchsbaum HJ; Morrison J
Gynecol Oncol; 1975 Dec; 3(4):325-34. PubMed ID: 1213596
[No Abstract] [Full Text] [Related]
15. Minimally invasive pelvic exenteration for gynaecological malignancy: A single-centre case series and review of the literature.
Karkia R; Tailor A; Ellis P; Madhuri T; Scala A; Read J; Perry M; Patil K; Blackburn A; Butler-Manuel S; Chatterjee J
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():56-61. PubMed ID: 35584578
[TBL] [Abstract][Full Text] [Related]
16. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
17. A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
Husain A; Akhurst T; Larson S; Alektiar K; Barakat RR; Chi DS
Gynecol Oncol; 2007 Jul; 106(1):177-80. PubMed ID: 17477959
[TBL] [Abstract][Full Text] [Related]
18. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
19. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
20. Free latissimus dorsi myocutaneous flap for pelvic floor reconstruction following pelvic exenteration.
Abdou AH; Li L; Khatib-Chahidi K; Troja A; Looft P; Gudewer EM; Raab HR; Antolovic D
Int J Colorectal Dis; 2016 Feb; 31(2):385-91. PubMed ID: 26410267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
